413 related articles for article (PubMed ID: 32627972)
1. Artificial Intelligence and Machine Learning in Computational Nanotoxicology: Unlocking and Empowering Nanomedicine.
Singh AV; Ansari MHD; Rosenkranz D; Maharjan RS; Kriegel FL; Gandhi K; Kanase A; Singh R; Laux P; Luch A
Adv Healthc Mater; 2020 Sep; 9(17):e1901862. PubMed ID: 32627972
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence and machine learning disciplines with the potential to improve the nanotoxicology and nanomedicine fields: a comprehensive review.
Singh AV; Varma M; Laux P; Choudhary S; Datusalia AK; Gupta N; Luch A; Gandhi A; Kulkarni P; Nath B
Arch Toxicol; 2023 Apr; 97(4):963-979. PubMed ID: 36878992
[TBL] [Abstract][Full Text] [Related]
3. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
Chou WC; Lin Z
Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
[TBL] [Abstract][Full Text] [Related]
4. An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice.
Chou WC; Chen Q; Yuan L; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE; Lin Z
J Control Release; 2023 Sep; 361():53-63. PubMed ID: 37499908
[TBL] [Abstract][Full Text] [Related]
5. A concise review: the synergy between artificial intelligence and biomedical nanomaterials that empowers nanomedicine.
Hayat H; Nukala A; Nyamira A; Fan J; Wang P
Biomed Mater; 2021 Aug; 16(5):. PubMed ID: 34280907
[TBL] [Abstract][Full Text] [Related]
6. Machine Learning and Artificial Intelligence in Toxicological Sciences.
Lin Z; Chou WC
Toxicol Sci; 2022 Aug; 189(1):7-19. PubMed ID: 35861448
[TBL] [Abstract][Full Text] [Related]
7. Artificial intelligence to bring nanomedicine to life.
Serov N; Vinogradov V
Adv Drug Deliv Rev; 2022 May; 184():114194. PubMed ID: 35283223
[TBL] [Abstract][Full Text] [Related]
8. Predicting Nanoparticle Delivery to Tumors Using Machine Learning and Artificial Intelligence Approaches.
Lin Z; Chou WC; Cheng YH; He C; Monteiro-Riviere NA; Riviere JE
Int J Nanomedicine; 2022; 17():1365-1379. PubMed ID: 35360005
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence in drug design.
Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
[TBL] [Abstract][Full Text] [Related]
10. Re-envisioning the design of nanomedicines: harnessing automation and artificial intelligence.
Zaslavsky J; Bannigan P; Allen C
Expert Opin Drug Deliv; 2023 Feb; 20(2):241-257. PubMed ID: 36644850
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine Ex Machina: Between Model-Informed Development and Artificial Intelligence.
Villa Nova M; Lin TP; Shanehsazzadeh S; Jain K; Ng SCY; Wacker R; Chichakly K; Wacker MG
Front Digit Health; 2022; 4():799341. PubMed ID: 35252958
[TBL] [Abstract][Full Text] [Related]
12. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
13. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X; Zhao Y; Qi Z; Hou S; Chen J
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
[TBL] [Abstract][Full Text] [Related]
14. Knowledge Gaps in Generating Cell-Based Drug Delivery Systems and a Possible Meeting with Artificial Intelligence.
Mozafari N; Mozafari N; Dehshahri A; Azadi A
Mol Pharm; 2023 Aug; 20(8):3757-3778. PubMed ID: 37428824
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence in liver cancers: Decoding the impact of machine learning models in clinical diagnosis of primary liver cancers and liver cancer metastases.
Bakrania A; Joshi N; Zhao X; Zheng G; Bhat M
Pharmacol Res; 2023 Mar; 189():106706. PubMed ID: 36813095
[TBL] [Abstract][Full Text] [Related]
16. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology.
Domingues C; Santos A; Alvarez-Lorenzo C; Concheiro A; Jarak I; Veiga F; Barbosa I; Dourado M; Figueiras A
ACS Nano; 2022 Jul; 16(7):9994-10041. PubMed ID: 35729778
[TBL] [Abstract][Full Text] [Related]
17. Applying artificial intelligence and computational modeling to nanomedicine.
Hamilton S; Kingston BR
Curr Opin Biotechnol; 2024 Feb; 85():103043. PubMed ID: 38091874
[TBL] [Abstract][Full Text] [Related]
18. Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling.
Lin Z; Aryal S; Cheng YH; Gesquiere AJ
ACS Nano; 2022 Dec; 16(12):19722-19754. PubMed ID: 36520546
[TBL] [Abstract][Full Text] [Related]
19. Computational pharmaceutics - A new paradigm of drug delivery.
Wang W; Ye Z; Gao H; Ouyang D
J Control Release; 2021 Oct; 338():119-136. PubMed ID: 34418520
[TBL] [Abstract][Full Text] [Related]
20. Merging data curation and machine learning to improve nanomedicines.
Chen C; Yaari Z; Apfelbaum E; Grodzinski P; Shamay Y; Heller DA
Adv Drug Deliv Rev; 2022 Apr; 183():114172. PubMed ID: 35189266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]